Publication Name	World Journal of Gastroenterology
Manuscript ID	16780
Country	Lebanon

Received	2015-01-29 08:40
Peer-Review Started	2015-01-29 10:56
To Make the First Decision	2015-03-10 17:44
Return for Revision	2015-03-16 08:58
Revised	2015-03-22 08:05
Second Decision	2015-04-23 08:23
Accepted by Journal Editor-in-Chief	2015-04-23 17:35
Accepted by Executive Editor-in-Chief	2015-05-04 18:07
Articles in Press	2015-05-04 18:07
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-07-07 09:33
Publish the Manuscript Online	2015-07-30 11:17

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Editorial
Article Title	Gastrointestinal cancers in the era of theranostics: Updates and future perspectives
Manuscript Source	Invited Manuscript
All Author List	Marwan Ghosn, Hampig Raphael Kourie and Samer Tabchi
Funding Agency and Grant Number
Corresponding Author	Marwan Ghosn, MD, Department of Oncology, Faculty of Medicine, Saint Joseph University, Alfred Naccache Street, PO Box 166830, Beirut 1104-2020, Lebanon. mghosn.hdf@usj.edu.lb
Key Words	Theranostics; Gastrointestinal cancer; Nanoparticles; Nanotheranostics; Molecular targeting
Core Tip	This editorial presents briefly the concept and evolution of theranostics. It describes the actual use of this treatment modality in gastrointestinal (GI) cancer going from the success story of theranostics in pancreatic neuroendocrine tumors to the promising results in gastric and colon cancer. Future perspectives of theranostics in GI cancers in nanotechnology and biomarkers fields are also reported in the end of this editorial.
Publish Date	2015-07-30 11:17
Citation	Ghosn M, Kourie HR, Tabchi S. Gastrointestinal cancers in the era of theranostics: Updates and future perspectives. World J Gastroenterol 2015; 21(28): 8473-8477
URL	http://www.wjgnet.com/1007-9327/full/v21/i28/8473.htm
DOI	http://dx.doi.org/10.3748/wjg.v21.i28.8473

Full Article (PDF)	WJG-21-8473.pdf
Full Article (Word)	WJG-21-8473.doc
Manuscript File	16780-Review.docx
Answering Reviewers	16780-Answering reviewers.pdf
Audio Core Tip	16780-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	16780-Conflict-of-interest statement.pdf
Copyright License Agreement	16780-Copyright assignment.pdf
Peer-review Report	16780-Peer-reivew(s).pdf
Journal Editor-in-Chief Review Report	16780-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	16780-Scientific misconduct check.pdf
Scientific Editor Work List	16780-Scientific editor work list.pdf